Freestone Capital Holdings, LLC Omeros Corp Transaction History

Freestone Capital Holdings, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.52 - $23.53 $60,519 - $98,073	-4,168 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.14 - $15.19 $5,070 - $7,595	500 Added 13.63%	4,168 $59.5 Million
Q3 2020 Nov 06, 2020	BUY	$9.57 - $21.32 $35,102 - $78,201	3,668 New	3,668 $37,000
Q2 2019 Aug 05, 2019	SELL	$15.0 - $19.62 $175,020 - $228,926	-11,668 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$17.73 - $26.69 $206,873 - $311,418	11,668 New	11,668 $285,000

142

26.9M

959K

732K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $544M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Freestone Capital Holdings, LLC with notifications on news.